Search

Search Constraints

You searched for: Subject 610.5

Search Results

1835. A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial. Issue 10275 (20th February 2021)